The size of the Hernia Mesh Devices Market in the Asia-Pacific was worth USD 0.63 billion in 2021 and is projected to be growing at a CAGR of 5.1%, to touch USD 0.81 billion by 2026.
The treatment of hernia includes terminating the weak spot present in the muscle through which the intestinal content is distended. Presently, there are two treatment options existing – hernia repair surgeries using sutures, and hernia repair surgeries using mesh. The mending of hernia through surgery using mesh does not create any stress on tissues or muscles; the mesh bridges the gap in the muscle/hernia orifice with few stiches or staples.
The use of mesh also helps alleviate pain and reduces the chances of recurrence. Many types of mesh products are available in the market, but surgeons typically use a sterile, woven material made from a synthetic plastic-like material, such as polypropylene. The mesh can be in the form of a patch that goes under or over the weakness, or it can be in the form of a plug that goes inside the hole. Mesh is very sturdy and strong, yet extremely thin
The growth of the Asia-Pacific Hernia Mesh Devices Market is driven by factors such as increasing incidence of obesity, which is a result of lack of physical activity and an unhealthy diet. Furthermore, excessive physical activity and the growing geriatric population are set to boost market growth in the future. However, strict regulation of product approval, the availability of alternative treatment techniques for hernia damage repair and the high incidences of mesh failure and resulting chronic pains are projected to be the major restraints of market growth.
This research report has been segmented and sub-segmented into the following categories:
By Hernia Type:
By Product Type:
By Country:
Geographically, Factors such as growing elderly population with consequent cardiovascular ailments, and growing disposable incomes due to emerging economies in countries such as India and China are expected to lead the growth of the market in this region. Asia-Pacific is a fast-developing Hernia Mesh Devices Market which is expected to grow at the highest CAGR, due to the improving infrastructure, availability of massive untapped markets and enormous population base. The low manufacturing cost of these products are upholding a very healthy environment for market growth in this region.
Promising companies dominating the Asia Pacific Hernia Mesh Devices Market are Medtronic (U.S.), Ethicon, Inc. (U.S.), C.R. Bard, Inc. (U.S.), Atrium (Sweden), W.L. Gore & Associates (Germany), Lifecell Corporation (U.S.), and B. Braun Melsungen AG (Germany).
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Hernia Type
5.1.1 Introduction
5.1.2 Inguinal
5.1.3 Umbilical
5.1.4 Hiatal
5.1.5 Femoral
5.1.6 Incisional
5.1.7 Others
5.1.5 Y-o-Y Growth Analysis, By Hernia Type
5.1.6 Market Attractiveness Analysis, By Hernia Type
5.1.7 Market Share Analysis, By Hernia Type
5.2 Product Type
5.2.1 Introduction
5.2.2 Synthetic Mesh
5.2.2.1 Mesh Structure
5.2.2.2 Mesh Absorbance
5.2.3 Biological Mesh
5.2.4 Y-o-Y Growth Analysis, By Product Type
5.2.5 Market Attractiveness Analysis, By Product Type
5.2.6 Market Share Analysis, By Product Type
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Hernia Type
6.1.3.3 By Product Type
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Hernia Type
6.1.4.3 By Product Type
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Hernia Type
6.1.5.3 By Product Type
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Medtronic
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 StemCells
8.3 Cryo Cell International
8.4 Geron Corporation
8.5 Mesoblast
8.2 Ethicon
8.3 C R Bard
8.4 Atrium
8.5 W L Gore and Associates
8.6 Lifecell Corporation
8.7 B Braun Melsungen
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
